Transforming Validation of Automated Systems: How CSV Life Science Delivers With Kneat

Join us for an exclusive webinar on how digitalization is transforming validation of automated systems across the life sciences industry.

Hosted by digital validation experts Pablo Munoz Pierattini, CSV & CSA Manager at CSV Life Science, and Paul Smith, Partner Success Manager at Kneat, this session includes digitalization best practices for validating automated technologies, Distributed Control Systems (DCS) and Supervisory Control and Data Acquisition (SCADA), ensuring organizations meet all regulatory requirements.

Register now and discover the tangible benefits of transitioning from traditional, paper-based validation methods to a fully digital, streamlined approach.

Attend to Learn:

• How digital validation reduces complexity in DCS and SCADA validation.
• Key benefits of paperless solutions, including improved accuracy, minimized errors, and simplified workflows.
• The regulatory advantages of adopting digital validation for compliance.
• Real-world examples of how CSV Life Science helps the life sciences industry to enhance productivity and reduce manual efforts with Kneat Gx.

Presented by:

Pablo Munoz Pierattini, CSV & CSA Manager, CSV Life Science

Pablo Munoz Pierattini holds a degree in Chemistry and a Master’s in Cybersecurity, specializing in Computer System Validation (CSV) and IT Quality and Compliance. Formerly a Validation Manager at a pharmaceutical company, he now leads CSV and IT Compliance in CSV Life Science Group, overseeing computerized systems validation and regulatory adherence for leading pharmaceutical companies in global regulated environments.

Paul Smith, Partner Success Manager, Kneat

Paul is responsible for developing and managing business relationships to add value to clients and validation service providers operating across highly regulated industries. Prior to joining Kneat in 2019, Paul worked in various validation functions within the life sciences industry. He holds a BSc in Biological Sciences and a PhD in Cancer & Molecular Biology from the University of East Anglia, UK.